Antacid Lawsuit Gastrointestinal Cancer From Nexium Or Prilosec
If you develop esophageal cancer, stomach cancer, or liver tumor after consuming Nexium, Prilosec, Prevacid, or a prescription antacid, contact the 'antacid advocate' today for a free confidential consultation. Several medical studies have linked these drugs, called proton pump inhibitors, to an increased risk of gastrointestinal cancer.
What does the proton pump inhibitor case say?
Proton pump inhibitors are considered a last resort in treating acid reflux conditions such as indigestion, dyspepsia, GERD, acid reflux, and peptic ulcers. Prilosec was the first, soon followed by Prevacid and Nexium, but they are all essentially the same: a pyridine and a benzimidazole unit attached to a methylsulfonyl group.
Image Source: Google
All PPIs work in a similar way by blocking the gastric parietal cell proton pump, which is the last step before the stomach produces acid. The Food and Drug Administration has approved six proton pump inhibitors to treat gastrointestinal problems:
- Omeprazole / Prilosec
- Esomeprazole / Nexium
- Lansoprazole / prevacid
- Dexlanzoprazole / dexilant
- Pantoprazole / proton
- Rabeprazole / AcipHex
Neither of these drugs warns that taking PPIs is associated with an increased risk of stomach cancer in people taking them. Drug manufacturers do not mention these as side effects in their advertisements, in prescribing information for doctors, or in medication guides given to patients.
Pharmaceutical companies don't even recommend taking PPIs for long periods of time because of the cancer risk, although modern science reveals that the long time a person consumes PPIs, the greater the risk. The lawsuit alleges that the companies behind these drugs should warn consumers and doctors about the risks of stomach and esophageal cancer. The research is still in its very early stages and there is no agreement on gastric cancer caused by proton pump inhibitors.